How reliable are G-protein-coupled receptor antibodies?
Open accessAbstract
A cluster of manuscripts in this issue of the Journal highlights a lack of selectivity of 49 antibodies against 19 subtypes of alpha(1)- and beta-adrenoceptors, muscarinic, dopamine and galanin receptors as well as vanilloid (TRPV1) receptors. Taken together these data demonstrate that lack of selectivity appears to be the rule rather than the exception for antibodies against G-protein-coupled and perhaps also other receptors. Thus, the previously often applied validation of such antibodies by the disappearance of staining in the presence of blocking peptide, i.e. the antigen against which the antibody was raised, alone is insufficient to demonstrate specificity. We propose that receptor antibodies should be validated by at least one of the following techniques: a) disappearance of staining in knock-out animals of the target receptor, b) reduction of staining upon knock-down approaches such as siRNA treatment, c) selectivity of staining in immunoblots or immunocytochemistry for the target receptor vs. related subtypes when expressed in the same cell line and/or d) antibodies raised against multiple distinct epitopes of a receptor yielding very similar staining patterns. Other issues of consideration to obtain reliable results based on receptor antibodies in applications such as immunohistochemistry or immunoblotting are also being discussed.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There is uncertainty around the usefulness of antibodies against GPCRs.
“However, there is uncertainty around the usefulness of antibodies against GPCRs (Michel et al., 2009”
From Self-reported symptom burden in postural orthostatic tachycardia syndrome (POTS): A narrative review of observational and interventional studies (2023) · cites this paper as Michel et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Chen, W., Mahadomrongkul, V., Berger, U. V., Bassan, M., DeSilva, T. M., Tanaka, K., Irwin, N., Aoki, C. J., & Rosenberg, P. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1586-03.2004 · Cited by 267 · see citing works
Impact of GPCRs in clinical medicine: Monogenic diseases, genetic variants and drug targets
Insel, P. A., Tang, C., Hahntow, I. N., & Michel, M. C. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.029 · Cited by 178 · see citing works
Self-citationTen commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific
Jensen, B. C., Swigart, P. M., & Simpson, P. C. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-008-0368-6 · Cited by 176 · see citing works
Antibodies as valuable neuroscience research tools versus reagents of mass distraction
Rhodes, K. J., & Trimmer, J. S. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2728-06.2006 · Cited by 162 · see citing works
Expression and functional role of β-adrenoceptors in the human urinary bladder urothelium
Otsuka, A., Shinbo, H., Matsumoto, R., KURITA, Y., & Ozono, S. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0274-y · Cited by 162 · see citing works
Pradidarcheep, W., Stallen, J., Labruyère, W. T., Dabhoiwala, N. F., Michel, M. C., & Lamers, W. H. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-009-0393-0 · Cited by 152 · see citing works
Self-citationJositsch, G., Papadakis, T., Haberberger, R. V., Wolff, M., Wess, J., & Kummer, W. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0365-9 · Cited by 143 · see citing works
Distribution and regulation of protein expression of the free fatty acid receptor GPR120
Miyauchi, S., Hirasawa, A., Iga, T., Liu, N., Itsubo, C., Sadakane, K., Hara, T., & Tsujimoto, G. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0390-8 · Cited by 143 · see citing works
Self-citation1-Adrenergic receptors prevent a maladaptive cardiac response to pressure overload
O’Connell, T. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci22811 · Cited by 141 · see citing works
Tanaka, T., Yano, T., Adachi, T., Koshimizu, T., Hirasawa, A., & Tsujimoto, G. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0250-y · Cited by 117 · see citing works
Self-citationCharrua, A., Cruz, C. D., Narayanan, S., Gharat, L. A., Gullapalli, S., Cruz, F., & Avelino, A. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.08.121 · Cited by 108 · see citing works
Lack of Specificity of Commercially Available Antisera: Better Specifications Needed
Pradidarcheep, W., Labruyère, W. T., Dabhoiwala, N. F., & Lamers, W. H. (2008) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2008.952101 · Cited by 97 · see citing works
Tools to study β3-adrenoceptors
Vrydag, W., & Michel, M. C. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0127-5 · Cited by 94 · see citing works
Self-citationHerber, D. L., Severance, E. G., Cuevas, J., Morgan, D., & Gordon, M. N. (2004) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540405201013 · Cited by 93 · see citing works
Where is TRPV1 expressed in the bladder, do we see the real channel?
Everaerts, W., Sepúlveda, M. R., Gevaert, T., Roskams, T., Nilius, B., & Ridder, D. J. M. K. D. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0391-7 · Cited by 89 · see citing works
Lack of specificity of antibodies directed against human beta-adrenergic receptors
Hamdani, N., & van der Velden, J. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-009-0392-1 · Cited by 84 · see citing works
Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice
Lü, X., & Bartfai, T. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-009-0394-z · Cited by 70 · see citing works
Should we be cautious on the use of commercially available antibodies to dopamine receptors?
Bodei, S., Arrighi, N., Spano, P., & Sigala, S. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0384-6 · Cited by 55 · see citing works
Penn, R. B. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0263-1 · Cited by 54 · see citing works
The detection of the non-M2 muscarinic receptor subtype in the rat heart atria and ventricles
Mysliveček, J., Klein, M., Nováková, M., & Říčný, J. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0285-8 · Cited by 27 · see citing works
Ibba, M., Kitayama, M., McDonald, J. L., Calò, G., Guerrini, R., Farkas, J., Tóth, G., & Lambert, D. G. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0350-3 · Cited by 23 · see citing works
van Diepen, H. C., Schlicker, E., & Michel, M. C. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0327-2 · Cited by 20 · see citing works
Self-citationThe use of receptor-specific antibodies to study G-protein-coupled receptors.
Gupta, A., & Devi, L. A. (2006) · PubMed · Cited by 19 · see citing works
Similarities and differences in the autonomic control of airway and urinary bladder smooth muscle
Michel, M. C., & Parra, S. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0316-5 · Cited by 18 · see citing works
Self-citationMysliveček, J., Duysen, E. G., & Lockridge, O. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0184-4 · Cited by 12 · see citing works
Jongsma, M. A., Florczyk, U., Hendriks‐Balk, M., Michel, M. C., Peters, S. L. M., & Alewijnse, A. E. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0164-8 · Cited by 12 · see citing works
Self-citationGeneration, Use, and Validation of Receptor-Selective Antibodies
Mackrill, J. J. (2004) · Humana Press eBooks · doi:10.1385/1-59259-754-8:047 · Cited by 8 · see citing works
(2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20663 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Pyke, C., Heller, R. S., Kirk, R. K., Ørskov, C., Reedtz-Runge, S., Kaastrup, P., Hvelplund, A., Bardram, L., Calatayud, D., & Knudsen, L. B. (2014) · Endocrinology · doi:10.1210/en.2013-1934 · Cited by 876 · see citing works
Reproducibility crisis: Blame it on the antibodies
Baker, M. (2015) · Nature · doi:10.1038/521274a · Cited by 830 · see citing works
Bordeaux, J., Welsh, A. W., Agarwal, S., Killiam, E. J., Baquero, M. T., Hanna, J. A., Anagnostou, V., & Rimm, D. L. (2010) · BioTechniques · doi:10.2144/000113382 · Cited by 597 · see citing works
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
Panula, P., Chazot, P. L., Cowart, M., Gutzmer, R., Leurs, R., Liu, W. L., Stark, H., Thurmond, R. L., & Haas, H. L. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010249 · Cited by 578 · see citing works
Daugherty, A., Tall, A. R., Daemen, M. J. A. P., Falk, E., Fisher, E. A. A., García‐Cardeña, G., Lusis, A. J., Owens, A. P., Rosenfeld, M. E., & Virmani, R. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atv.0000000000000062 · Cited by 316 · see citing works
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J. R., & Gaskill, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 319 · see citing works
Trifilieff, P., Rives, M., Urizar, E., Piskorowski, R. A., Vishwasrao, H. D., Castrillon, J., Schmauss, C., Slättman, M., Gullberg, M. T., & Javitch, J. A. (2011) · BioTechniques · doi:10.2144/000113719 · Cited by 250 · see citing works
Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges
Berry, M. D., Gainetdinov, R. R., Hoener, M. C., & Shahid, M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.07.002 · Cited by 232 · see citing works
O’Connell, T. D., Jensen, B. C., Baker, A. J., & Simpson, P. C. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007203 · Cited by 205 · see citing works
Opportunities for therapeutic antibodies directed at G-protein-coupled receptors
Hutchings, C. J., Koglin, M., Olson, W. C., & Marshall, F. H. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.91 · Cited by 198 · see citing works
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence
Alicic, R. Z., Cox, E. J., Neumiller, J. J., & Tuttle, K. R. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00367-2 · Cited by 193 · see citing works
Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis
Ichimura, A., Hirasawa, A., Hara, T., & Tsujimoto, G. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.05.003 · Cited by 191 · see citing works
Self-citationDaugherty, A., Tall, A. R., Daemen, M. J. A. P., Falk, E., Fisher, E. A. A., García‐Cardeña, G., Lusis, A. J., Owens, A. P., Rosenfeld, M. E., & Virmani, R. (2017) · Circulation Research · doi:10.1161/res.0000000000000169 · Cited by 182 · see citing works
Distribution of the Endocannabinoid System in the Central Nervous System
Hu, S. S., & Mackie, K. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_3 · Cited by 177 · see citing works
Abrantes, H. D. C., Briquet, M., Schmuziger, C., Restivo, L., Puyal, J., Rosenberg, N., Rocher, A., Offermanns, S., & Chatton, J. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2092-18.2019 · Cited by 174 · see citing works
Molecular and cellular analysis of human histamine receptor subtypes
Seifert, R., Straßer, A., Schneider, E. H., Neumann, D., Dove, S., & Buschauer, A. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.11.001 · Cited by 168 · see citing works
The Glucagon-Like Peptide-1 Receptor—or Not?
Pyke, C., & Knudsen, L. B. (2013) · Endocrinology · doi:10.1210/en.2012-2124 · Cited by 154 · see citing works
Animal immunization, in vitro display technologies, and machine learning for antibody discovery
Laustsen, A. H., Greiff, V., Karatt-Vellatt, A., Muyldermans, S., & Jenkins, T. P. (2021) · Trends in Biotechnology · doi:10.1016/j.tibtech.2021.03.003 · Cited by 157 · see citing works
Neuropeptide and small transmitter coexistence: Fundamental studies and relevance to mental illness
Hökfelt, T., Barde, S., Xu, Z.-Q. D., Kuteeva, E., Rüegg, J., Le Maitre, E., Risling, M., Kehr, J., Ihnatko, R., Theodorsson, E., et al. (2018) · Frontiers in Neural Circuits · doi:10.3389/fncir.2018.00106 · Cited by 139 · see citing works
Nerve growth factor in bladder dysfunction: Contributing factor, biomarker, and therapeutic target
Ochodnický, P., Cruz, C. D., Yoshimura, N., & Michel, M. C. (2011) · Neurourology and Urodynamics · doi:10.1002/nau.21022 · Cited by 128 · see citing works
Self-citationAdrenergic Receptors in Individual Ventricular Myocytes
Myagmar, B., Flynn, J. M., Cowley, P. M., Swigart, P. M., Montgomery, M. D., Thai, K., Nair, D., Gupta, R., Deng, D. X.-F., Hosoda, C., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.310520 · Cited by 127 · see citing works
Stanić, D., Dubois, S., Chua, H. K., Tonge, B. J., Rinehart, N., Horne, M. K., & Boon, W. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090451 · Cited by 124 · see citing works
Pasquier, E., André, N., Street, J. A., Chougule, A., Rekhi, B., Ghosh, J., Philip, D. S. J., Meurer, M., MacKenzie, K. L., Kavallaris, M., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.02.026 · Cited by 124 · see citing works
Synthetic antibodies: Concepts, potential and practical considerations
Miersch, S., & Sidhu, S. S. (2012) · Methods · doi:10.1016/j.ymeth.2012.06.012 · Cited by 120 · see citing works
Huang, P., Chen, C., Mague, S. D., Blendy, J. A., & Liu‐Chen, L. (2011) · Biochemical Journal · doi:10.1042/bj20111050 · Cited by 113 · see citing works
Six Commercially Available Angiotensin II AT1 Receptor Antibodies are Non-specific
Benický, J., Hafko, R., Sánchez-Lemus, E., Aguilera, G., & Saavedra, J. M. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9862-y · Cited by 112 · see citing works
Animal‐free alternatives and the antibody iceberg
Gray, A., Bradbury, A. R. M., Knappik, A., Plückthun, A., Borrebaeck, C. A. K., & Dübel, S. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0687-9 · Cited by 108 · see citing works
Inhibitors of membranous adenylyl cyclases
Seifert, R., Lushington, G. H., Mou, T., Gille, A., & Sprang, S. R. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.10.006 · Cited by 104 · see citing works
Mass spectrometric epitope mapping
Opuni, K. F. M., Al‐Majdoub, M., Yefremova, Y., El‐Kased, R. F., Koy, C., & Glocker, M. O. (2016) · Mass Spectrometry Reviews · doi:10.1002/mas.21516 · Cited by 98 · see citing works
Plug-and-Play Protein Modification Using Homology-Independent Universal Genome Engineering
Gao, Y., Hisey, E. E., Bradshaw, T. W., Erata, E., Brown, W. E., Courtland, J. L., Uezu, A., Xiang, Y., Diao, Y., & Soderling, S. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.047 · Cited by 102 · see citing works
Graham, E. S., Angel, C. E., Schwarcz, L., Dunbar, P. R., & Glass, M. (2010) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201002300103 · Cited by 96 · see citing works
MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells
Parr, C., Katayama, S., Miki, K., Kuang, Y., Yoshida, Y., Morizane, A., Takahashi, J. B., Yamanaka, S., & Saito, H. (2016) · Scientific Reports · doi:10.1038/srep32532 · Cited by 91 · see citing works
Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer
Borcherding, D. C., Tong, W. S., Hugo, E. R., Barnard, D. F., Fox, S. R., LaSance, K., Shaughnessy, E., & Ben‐Jonathan, N. (2015) · Oncogene · doi:10.1038/onc.2015.369 · Cited by 90 · see citing works
Illuminating somatostatin analog action at neuroendocrine tumor receptors
Reubi, J. C., & Schönbrunn, A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.10.001 · Cited by 88 · see citing works
Hazell, G. G. J., Hindmarch, C. C. T., Pope, G. R., Roper, J. A., Lightman, S. L., Murphy, D., O’Carroll, A., & Lolait, S. J. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.07.002 · Cited by 85 · see citing works
Commercially Available Angiotensin II At2 Receptor Antibodies Are Nonspecific
Hafko, R., Villapol, S., Nostramo, R., Symes, A. J., Sabban, E. L., Inagami, T., & Saavedra, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069234 · Cited by 83 · see citing works
Eberwine, J. H., & Bartfai, T. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.010 · Cited by 82 · see citing works
Schneider, E. H., & Seifert, R. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.004 · Cited by 78 · see citing works
Adrenoceptors in white, brown, and brite adipocytes
Evans, B. A., Merlin, J., Bengtsson, T., & Hutchinson, D. S. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14631 · Cited by 76 · see citing works
Sampson, A. K., Hilliard, L. M., Moritz, K. M., Thomas, M. C., Tikellis, C., Widdop, R. E., & Denton, K. M. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00256.2011 · Cited by 75 · see citing works
Stanić, D., Mulder, J., Watanabe, M., & Hökfelt, T. G. M. (2011) · The Journal of Comparative Neurology · doi:10.1002/cne.22608 · Cited by 72 · see citing works
Commercially available antibodies against human and murine histamine H4-receptor lack specificity
Beermann, S., Seifert, R., & Neumann, D. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0700-4 · Cited by 72 · see citing works
Postnatal Ontogeny of Angiotensin Receptors and ACE2 in Male and Female Rats
Sampson, A. K., Moritz, K. M., & Denton, K. M. (2012) · Gender Medicine · doi:10.1016/j.genm.2011.12.003 · Cited by 71 · see citing works
Pooled extracellular receptor-ligand interaction screening using CRISPR activation
Chong, Z., Ohnishi, S., Yusa, K., & Wright, G. J. (2018) · Genome biology · doi:10.1186/s13059-018-1581-3 · Cited by 71 · see citing works
Cécyre, B., Thomas, S., Ptito, M., Casanova, C., & Bouchard, J. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0930-8 · Cited by 68 · see citing works
β−Adrenergic receptor subtype expression in myocyte and non-myocyte cells in human female bladder
Limberg, B. J., Andersson, K., Kullmann, F. A., Burmer, G. C., de Groat, W. C., & Rosenbaum, J. S. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1053-x · Cited by 66 · see citing works
Insel, P. A., Wilderman, A. S., Zambon, A. C., Snead, A. N., Murray, F., Aroonsakool, N., McDonald, D., Zhou, S. M., McCann, T., Zhang, L., et al. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.098129 · Cited by 66 · see citing works
Schönbrunn, A. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1230 · Cited by 66 · see citing works
Localization of Glucagon-Like Peptide-2 Receptor Expression in the Mouse
Yusta, B., Matthews, D., Koehler, J. A., Pujadas, G., Kaur, K. D., & Drucker, D. J. (2019) · Endocrinology · doi:10.1210/en.2019-00398 · Cited by 63 · see citing works
G Protein–Coupled Receptor Multimers: A Question Still Open Despite the Use of Novel Approaches
Vischer, H. F., Castro, M., & Pin, J. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099440 · Cited by 62 · see citing works
M 3 muscarinic receptor expression on suburothelial interstitial cells
Grol, S., Essers, P., van Koeveringe, G. A., Martínez‐Martínez, P., de Vente, J., & Gillespie, J. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08423.x · Cited by 62 · see citing works
Gotfredsen, C. F., Mølck, A.-M., Thorup, I., Nyborg, N. C. B., Salanti, Z., Knudsen, L. B., & Larsen, M. O. (2014) · Diabetes · doi:10.2337/db13-1087 · Cited by 60 · see citing works
Michel, M. C., & Korstanje, C. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.01.007 · Cited by 60 · see citing works
Self-citationRoncador, G., Engel, P., Maestre, L., Anderson, A. P., Cordell, J., Cragg, M. S., Šerbec, V. Č., Jones, M., Lisnić, V. J., Kremer, L., et al. (2015) · mAbs · doi:10.1080/19420862.2015.1100787 · Cited by 60 · see citing works
Prefrontal Dopaminergic Mechanisms of Extinction in Adolescence Compared to Adulthood in Rats
Zbukvic, I. C., Park, C. H. J., Ganella, D. E., Lawrence, A. J., & Kim, J. H. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00032 · Cited by 57 · see citing works
GLP-1 and Underlying Beneficial Actions in Alzheimer’s Disease, Hypertension, and NASH
Li, Q.-X., Gao, H., Guo, Y.-X., Wang, B.-Y., Hua, R.-X., Gao, L., Shang, H.-W., Lu, X., & Xu, J.-D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721198 · Cited by 56 · see citing works
Muscarinic Acetylcholine Receptors in the Urinary Tract
Andersson, K. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-16499-6_16 · Cited by 55 · see citing works
Relevance of Antibody Validation for Flow Cytometry
Kalina, T., Lundsten, K., & Engel, P. (2019) · Cytometry Part A · doi:10.1002/cyto.a.23895 · Cited by 54 · see citing works
Liu, Y., Li, B., Wang, X., Li, G., Shang, R., Yang, J., Wang, J., Zhang, M., Chen, Y., Zhang, Y., et al. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00022 · Cited by 53 · see citing works
Expression and functional role of β3‐adrenoceptors in the human ureter
Matsumoto, R., Otsuka, A., Suzuki, T., Shinbo, H., Mizuno, T., KURITA, Y., Mugiya, S., & Ozono, S. (2013) · International Journal of Urology · doi:10.1111/iju.12093 · Cited by 53 · see citing works
Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy
Doesch, A. O., Konstandin, M. H., Celik, S., Kristen, A. V., Frankenstein, L., Hardt, S. E., Göser, S., Kaya, Z., Katus, H. A., & Dengler, T. J. (2009) · Journal of Clinical Apheresis · doi:10.1002/jca.20204 · Cited by 53 · see citing works
Localisation of pre- and postsynaptic cholinergic markers in the human brain
Wevers, A. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.02.025 · Cited by 51 · see citing works
Modulation of lower urinary tract smooth muscle contraction and relaxation by the urothelium
Sellers, D., Chess‐Williams, R., & Michel, M. C. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1510-8 · Cited by 51 · see citing works
Self-citationP2Y Receptors in Immune Response and Inflammation
Duc, D. L., Schulz, A., Lede, V., Schulze, A., Thor, D., Brüser, A., & Schöneberg, T. (2017) · Advances in immunology · doi:10.1016/bs.ai.2017.05.006 · Cited by 50 · see citing works
Fehler, M., Broadley, K. J., Ford, W. R., & Kidd, E. J. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0554-1 · Cited by 49 · see citing works
Muscarinic Agonists and Antagonists: Effects on the Urinary Bladder
Sellers, D., & Chess‐Williams, R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-23274-9_16 · Cited by 49 · see citing works
Chen, C., Willhouse, A. H., Huang, P., Ko, N., Wang, Y., Xu, B., Huang, L., Kieffer, B. L., Barbe, M. F., & Liu‐Chen, L. (2020) · eNeuro · doi:10.1523/eneuro.0028-20.2020 · Cited by 48 · see citing works
The emerging pharmacology and function of GPR35 in the nervous system
Mackenzie, A. E., & Milligan, G. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.035 · Cited by 48 · see citing works
Dale, P., Černecká, H., Schmidt, M., Dowling, M. R., Charlton, S. J., Pieper, M. P., & Michel, M. C. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.03.003 · Cited by 48 · see citing works
Self-citationKoschatzky, S., Tschammer, N., & Gmeiner, P. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200020y · Cited by 48 · see citing works
Helsby, M. A., Leader, P. M., Fenn, J. R., Gülşen, T., Bryant, C., Doughton, G., Sharpe, B. P., Whitley, P. R., Caunt, C. J., James, K., et al. (2014) · BMC Cell Biology · doi:10.1186/1471-2121-15-6 · Cited by 47 · see citing works
Autonomic nervous control of the urinary bladder
Ochodnický, P., Uvelius, B., Andersson, K., & Michel, M. C. (2012) · Acta Physiologica · doi:10.1111/apha.12010 · Cited by 46 · see citing works
Self-citationAnalytical Protein Microarrays: Advancements Towards Clinical Applications
Sauer, U. (2017) · Sensors · doi:10.3390/s17020256 · Cited by 46 · see citing works
Tissue functions mediated by β3-adrenoceptors—findings and challenges
Michel, M. C., Ochodnický, P., & Summers, R. J. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0529-2 · Cited by 45 · see citing works
Self-citationPremer, C., Lamondin, C., Mitzey, A. M., Speth, R. C., & Brownfield, M. S. (2013) · International Journal of Hypertension · doi:10.1155/2013/175428 · Cited by 44 · see citing works
Brown, M. C., Joaquim, T., Chambers, R. S., Onisk, D., Yin, F., Moriango, J. M., Xu, Y.-C., Fancy, D. A., Crowgey, E., He, Y.-D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028718 · Cited by 44 · see citing works
Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
Bobkov, V., Arimont, M., Zarca, A. M., Groof, T. W. M. D., van der Woning, B., de Haard, H., & Smit, M. J. (2019) · Molecular Pharmacology · doi:10.1124/mol.119.116954 · Cited by 43 · see citing works
Evaluation of commercially available glucagon receptor antibodies and glucagon receptor expression
Billeschou, A., Johansen, C. D., Christensen, J. B., Kjeldsen, S. A. S., Galsgaard, K. D., Winther‐Sørensen, M., Serizawa, R., Hornum, M., Porrini, E., Pedersen, J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04242-7 · Cited by 42 · see citing works
Kullmann, F. A., Limberg, B. J., Artim, D. E., Shah, M. A., Downs, T. R., Contract, D., Wos, J. A., Rosenbaum, J. S., & de Groat, W. C. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155010 · Cited by 42 · see citing works
Guidelines for manuscript submission in the peer-reviewed pharmacological literature
Mullane, K., Enna, S. J., Piette, J. G., & Williams, M. J. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.023 · Cited by 41 · see citing works
Gastrointestinal Hormones and Their Targets
Rehfeld, J. F. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0897-4_7 · Cited by 41 · see citing works
Anastasio, N. C., Lanfranco, M. F., Bubar, M. J., Seitz, P. K., Stutz, S. J., McGinnis, A. G., Watson, C. S., & Cunningham, K. A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06694.x · Cited by 39 · see citing works
Differential Actions of Muscarinic Receptor Subtypes in Gastric, Pancreatic, and Colon Cancer
Schledwitz, A., Sundel, M. H., Alizadeh, M. A., Hu, S., Xie, G., & Raufman, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313153 · Cited by 39 · see citing works
Specificity evaluation of antibodies against human β3-adrenoceptors
Černecká, H., Ochodnický, P., Lamers, W. H., & Michel, M. C. (2012) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-012-0767-6 · Cited by 39 · see citing works
Self-citationAn array of 60,000 antibodies for proteome-scale antibody generation and target discovery
Wang, Z., Li, Y., Hou, B., Pronobis, M. I., Wang, M., Wang, Y., Cheng, G., Zhang, Z., Wang, Y., Tang, Y., et al. (2020) · Science Advances · doi:10.1126/sciadv.aax2271 · Cited by 38 · see citing works
Schirmer, B., & Neumann, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116116 · Cited by 39 · see citing works
Intact Transition Epitope Mapping (ITEM)
Yefremova, Y., Opuni, K. F. M., Danquah, B. D., Thiesen, H., & Glocker, M. O. (2017) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-017-1654-7 · Cited by 36 · see citing works
Ellenbroek, J. H., Arioglu‐Inan, E., & Michel, M. C. (2018) · Neurourology and Urodynamics · doi:10.1002/nau.23786 · Cited by 37 · see citing works
Self-citationDistribution of Y-Receptors in Murine Lingual Epithelia
Hurtado, M. D., Acosta, A. J., Riveros, P. P., Baum, B. J., Ukhanov, K., Brown, A. R., Dotson, C. D., Herzog, H., & Zolotukhin, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046358 · Cited by 37 · see citing works
Stadler, C., Hjelmare, M., Neumann, B., Jonasson, K., Pepperkok, R., Uhlén, M., & Lundberg, E. K. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.01.030 · Cited by 37 · see citing works
Lack of specificity shown by P2Y6 receptor antibodies
Yu, W., & Hill, W. G. (2013) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-013-0894-8 · Cited by 36 · see citing works
Cannabinoids: Potential Targets for Bladder Dysfunction
Ruggieri, M. R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-16499-6_20 · Cited by 36 · see citing works
Sereni, F., Monte, M. D., Filippi, L., & Bagnoli, P. (2015) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-015-1165-7 · Cited by 35 · see citing works
Evans, A. E., Tripathi, A., LaPorte, H. M., Brueggemann, L. I., Singh, A. K., Albee, L. J., Byron, K. L., Tarasova, N. I., Volkman, B. F., Cho, T., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060971 · Cited by 35 · see citing works
Albee, L. J., Eby, J. M., Tripathi, A., LaPorte, H. M., Gao, X., Volkman, B. F., Gaponenko, V., & Majetschak, M. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006575 · Cited by 33 · see citing works
β-Adrenoceptor agonist effects in experimental models of bladder dysfunction
Michel, M. C., Ochodnický, P., Homma, Y., & Igawa, Y. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.03.014 · Cited by 32 · see citing works
Self-citationThe controversial role of the vagus nerve in mediating ghrelin's actions: gut feelings and beyond
Perelló, M., Cornejo, M. P., Francesco, P. N. D., Fernández, G., Gautron, L., & Valdivia, L. S. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.03.003 · Cited by 32 · see citing works
Monocyte chemotactic protein 3 is a homing factor for circulating angiogenic cells
Bousquenaud, M., Schwartz, C., Léonard, F., Rolland-Turner, M., Wagner, D., & Devaux, Y. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs140 · Cited by 31 · see citing works
In vivo mapping of a GPCR interactome using knockin mice
Degrandmaison, J., Abdallah, K., Blais, V., Génier, S., Lalumière, M.-P., Bergeron, F., Cahill, C. M., Boulter, J., Lavoie, C. L., Parent, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917906117 · Cited by 30 · see citing works
Reporting research antibody use: how to increase experimental reproducibility
Helsby, M. A., Fenn, J. R., & Chalmers, A. D. (2013) · F1000Research · doi:10.12688/f1000research.2-153.v2 · Cited by 29 · see citing works
- Authors
- Michel, M. C., Wieland, T., & Tsujimoto, G.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Heidelberg University (DE)
- Kyoto University (JP)
- Corresponding author
- Michel, Martin C.
- Venue
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Published
- 2009-01-27
- Volume
- 379
- Issue
- 4
- Pages
- 385-388
- ISSN
- 0028-1298 (ISSN-L)
- 1432-1912
- OpenAlex
- W2029187954
- Cited by
- 306
- References
- 28
- Citations by year
- 2026: 2 · 2025: 11 · 2024: 18 · 2023: 19 · 2022: 19 · 2021: 23 · 2020: 16 · 2019: 19 · 2018: 14 · 2017: 21 · 2016: 14 · 2015: 30 · 2014: 23 · 2013: 18 · 2012: 21
- FWCI
- 7.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Naunyn-Schmiedeberg s Archives of Pharmacology (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- UvA-DARE (University of Amsterdam) (acceptedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- G protein-coupled receptors, antibody specificity, cross-reactivity, adrenergic receptors, muscarinic receptors, dopamine receptors, galanin receptors, TRPV1, blocking peptides, siRNA knockdown, epitope specificity, immunohistochemistry, Western blot
- MeSH terms
- Animals, Antibodies, Antibody Specificity, Humans, Receptors, Adrenergic, Receptors, Dopamine, Receptors, Muscarinic, Conserved Sequence, Sequence Homology, Amino Acid, Editorial Policies, Receptors, G-Protein-Coupled, Receptors, Galanin, TRPV Cation Channels, Validation Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
